Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

WSE/SVE stock hub

WSE/SVE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

WSE/SVEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

225.1M

Warsaw Stock Exchange

Market data

Price

Recent price action with selectable time range.

WSE/SVEWSE/SVE

—

Loading chart…

In the news

Latest news · WSE/SVE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E50.4

P25 n/aP50 n/aP75 n/a

ROE6.4

P25 n/aP50 n/aP75 n/a

ROIC4.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All WSE/SVE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

PLN

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Poland
Country code	PL
Employees	239
Employees Change	5%
Employees Change Percent	2.14
Enterprise value	PLN 312.2M
Exchange	Warsaw Stock Exchange
Financial currency	PLN
First seen	2026-05-10
Industry	Biotechnology
Isin	PLBMDLB00018
Last refreshed	2026-05-10
Market cap	PLN 225.1M
Price	PLN 3.18
Price currency	PLN
Rev Per Employee	300,234.31x
Sector	Healthcare
Sic	2836
Symbol	wse/SVE
Website	https://synthaverse.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.35%
EV Earnings	41.36x
EV/EBIT	35.68x
EV/EBITDA	19.52x
EV/FCF	-11.55x
EV/Sales	4.98x
FCF yield	-12.01%
P/B ratio	1.85x
P/E ratio	50.37x
P/S ratio	3.14x
PE Ratio10 Y	104.27x
PE Ratio3 Y	68.91x
PE Ratio5 Y	117.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.32%
EBITDA Margin	27.79%
Gross margin	61.67%
Gross Profit	PLN 44.3M
Gross Profit Growth	25.83%
Gross Profit Growth Q	-80.28%
Gross Profit Growth3 Y	26.78%
Gross Profit Growth5 Y	16.02%
Net Income	PLN 7.6M
Net Income Growth	58.68%
Net Income Growth Years	0%
Net Income Growth3 Y	21.12%
Net Income Growth5 Y	24.91%
Pretax Margin	13.44%
Profit Margin	10.52%
Profit Per Employee	PLN 31,590
ROA	2.75
Roa5y	3.46
ROCE	4.86
ROE	6.45
Roe5y	7.56
ROIC	4.9
Roic5y	7.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.73%
Cagr1y	-38.27%
Cagr3y	-17.75%
Cagr5y	-19.66%
EPS Growth Years	0
OCF Growth5 Y	12.65%
Revenue Growth	22.44x
Revenue Growth Q	-64.28x
Revenue Growth Years	0x
Revenue Growth3 Y	20.36x
Revenue Growth5 Y	12.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	PLN 0.25
Assets	PLN 298.6M
Cash	PLN 760,000
Current Assets	PLN 45.6M
Current Liabilities	PLN 40M
Debt	PLN 80.4M
Debt EBITDA	PLN 4.03
Debt Equity	PLN 0.66
Debt FCF	PLN -2.97
Equity	PLN 121.5M
Interest Coverage	4
Liabilities	PLN 177.2M
Long Term Assets	PLN 253M
Long Term Liabilities	PLN 137.2M
Net Cash	PLN -79.6M
Net Cash By Market Cap	PLN -35.38
Net Debt EBITDA	PLN 3.99
Net Debt Equity	PLN 0.66
Tangible Book Value	PLN 119.8M
WACC	4.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.07
Inventory Turnover	2.18
Net Working Capital	PLN 22M
Quick ratio	0.83
Working Capital	PLN 3.2M
Working Capital Turnover	PLN 45.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Payout Ratio	29.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	110.6%
1Y total return	-38.25%
200-day SMA	4.08
3Y total return	-44.36%
50-day SMA	3.59
50-day SMA vs 200-day SMA	50under200
5Y total return	-66.53%
All Time High	32.8
All Time High Change	-90.3%
All Time High Date	2020-08-04
All Time Low	0.39
All Time Low Change	715.38%
All Time Low Date	2016-01-14
ATR	0.12
Beta	0.16
Beta1y	0.26
Beta2y	0.27
Ch YTD	-12.88
High	3.18
High52	5.91
High52 Date	2025-05-21
High52ch	-46.19%
Low	3.11
Low52	3
Low52 Date	2026-05-04
Low52ch	6%
Ma50ch	-11.37%
Price vs 200-day SMA	-21.96%
RSI	33.31
RSI Monthly	34.17
RSI Weekly	29.72
Sharpe ratio	-1.77x
Sortino ratio	-2.15
Tr YTD	-12.88
Tr1m	-12.15%
Tr1w	4.26%
Tr3m	-16.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	PLN 12.4M
Operating Income Growth	43.69
Operating Income Growth3 Y	31.27
Operating Income Growth5 Y	17.28
Operating margin	17.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38,168,345%
Net Borrowing	11,672,000
Shares Insiders	23.13%
Shares Institutions	0.08%
Shares Out	70,770,575
Shares Qo Q	0.92%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	PLN -27M
Average Volume	81,995.8x
CAPEX	PLN -41.8M
Ch10y	110.6
Ch1m	-12.15
Ch1w	4.26
Ch1y	-38.25
Ch3m	-16.54
Ch3y	-44.36
Ch5y	-66.53
Ch6m	-21.87
Change	0.95%
Change From Open	0.16
Close	3.15
Days Gap	0.79
Depreciation Amortization	7,511,998
Dollar Volume	75,245.2
Earnings Date	2026-04-30
EBIT	PLN 12.4M
EBITDA	PLN 19.9M
F Score	6
FCF	PLN -27M
FCF EV Yield	-8.66x
FCF Per Share	PLN -0.38
Financing CF	9,668,000
Fiscal Year End	December
Founded	1,944
Income Tax	PLN 2.1M
Investing CF	-25,888,000
Is Primary Listing	1
Last Earnings Date	2026-04-30
Last Report Date	2025-09-30
Ma150	3.85
Ma150ch	-17.3%
Ma20	3.44
Ma20ch	-7.61%
Net CF	-1,415,000
Next Earnings Date	2026-05-28
Open	3.18
P OCF Ratio	15.2
Position In Range	100
Ppne	244,437,000
Price Date	2026-05-08
Price EBITDA	PLN 11.29
Ptbv Ratio	1.88
Relative Volume	0.29x
Revenue	71,756,000x
Tax By Revenue	2.92x
Tax Rate	21.7%
Tr6m	-21.87%
Volume	23,662

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does WSE/SVE pay a dividend?

Capital-return profile for this ticker.

Performance

WSE/SVE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns WSE/SVE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Share of float held by funds and institutions

Insider ownership

+23.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

WSE/SVE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.3

Neutral momentum band

Price vs 200-day MA

-22.0%

50/200-day relationship not available

Beta (5Y)

0.16

Less volatile than the market

Sharpe ratio

-1.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About WSE/SVE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current wse/SVE stock rating?

wse/SVE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full wse/SVE analysis?

The full report lives at /stocks/wse/SVE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for wse/SVE?

The latest report frames wse/SVE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the wse/SVE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.